New Immunotherapy Strategies in Breast Cancer
| Autor: | Mu-Peng Li, Jie Tang, Wen-Jing Zeng, Han Yan, Xiao-Ping Chen, Cong-Min Zhang, Lin-Yu Yu |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Health Toxicology and Mutagenesis medicine.medical_treatment Immune checkpoint inhibitors lcsh:Medicine Breast Neoplasms Review Cancer Vaccines Targeted therapy immune checkpoint inhibitors 03 medical and health sciences breast cancer 0302 clinical medicine Breast cancer Internal medicine Antibodies Bispecific Humans Medicine Molecular Targeted Therapy skin and connective tissue diseases Chemotherapy business.industry lcsh:R Public Health Environmental and Occupational Health Cancer stimulatory molecule agonists Cell Cycle Checkpoints Immunotherapy medicine.disease Radiation therapy 030104 developmental biology 030220 oncology & carcinogenesis Pharmacogenomics bispecific antibodies business |
| Zdroj: | International Journal of Environmental Research and Public Health International Journal of Environmental Research and Public Health, Vol 14, Iss 1, p 68 (2017) |
| ISSN: | 1660-4601 |
| DOI: | 10.3390/ijerph14010068 |
| Popis: | Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|